Insomnia Chronic Completed Phase 4 Trials for Ramelteon (DB00980)

Also known as: Chronic Insomnia / Insomnia / Sleeplessness / Insomnia NOS

IndicationStatusPhase
DBCOND0080650 (Insomnia Chronic)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03461042The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic InsomniaTreatment
NCT00414102Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.Treatment
NCT00492232Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic InsomniaTreatment